Fundraise

Aevius raises $22M seed for whole-patient medical AI

What's the deal? Clinical intelligence startup Aevius LabsDealroom has a profile for this one. Try Dealroom → has raised $22 million in seed funding led by Insight Partners, chief executive officer Rowland Pettit told Axios Pro. The Boston-based company, founded in 2026, builds a foundation model called APOLLO that makes complete patient records searchable, predictable, and explainable in a single pass.

What's the endgame? Aevius wants to make entire patient records computable. APOLLO ingests labs, notes, medications, diagnoses, and history as one longitudinal trajectory, rather than running narrow single-task clinical models. It sells to health systems, payers, pharma, and public-health organisations that hold longitudinal patient data.

Why it matters: The founders have already built and sold one clinical AI company to Big Pharma, giving them a track record in the space.

By the numbers: At $22 million, the round sits in roughly the 99th percentile of all US health seed rounds on record, a sample of nearly 11,000 deals. That makes it unusually large for its stage.

Why now? The raise lands amid a surge of investment in AI built around clinical data. This month, Zus Health raised $33 million to expand its patient-record network, and Knit Health secured $35 million for a model trained on clinical decisions. Vera HealthDealroom has a profile for this one. Try Dealroom → raised $28.5 million in October for an AI clinical-search platform.

What could go wrong? Investors are backing distinct approaches to making medical information useful in care. Aevius's significance will depend on evidence of adoption and clinical value — neither of which the round itself proves.

The signal: Capital is flowing toward tools that turn messy medical records into computable data, not general-purpose healthcare chatbots. Aevius's outsized seed, backed by founders with a prior exit, shows how much investors are willing to pay to get in early on that bet.

Read more: Axios

Image credit: Aevius Labs

More top stories